Search...
Actinium Pharmaceuticals Elects Class III Directors
I'm PortAI, I can summarize articles.
Actinium Pharmaceuticals announced the election of Ajit S. Shetty and June S. Almenoff as Class III directors at its annual meeting on November 26, 2025. Their terms will expire at the 2028 annual meeting. This election is a re-election, and no replacement information or background details were disclosed. The original SEC filing is available for verification.
On November 26, 2025, Actinium Pharmaceuticals, Inc. announced the election of Ajit S. Shetty and June S. Almenoff as Class III directors at its annual meeting. Their terms will expire at the 2028 annual meeting.
| Individual | Ajit S. Shetty | June S. Almenoff |
| Role | Class III Director | Class III Director |
| Type of Change | Elected | Elected |
| Effective Date | Nov 26, 2025 | Nov 26, 2025 |
| Reason | Re-election | Re-election |
| Replacement Info | Not applicable | Not applicable |
| Background Details | Not disclosed | Not disclosed |
| Board/Committee Role Changes | Not disclosed | Not disclosed |
Original SEC Filing: Actinium Pharmaceuticals, Inc. [ ATNM ] - 8-K - Nov. 26, 2025
This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.
Source: TradingView The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments